Health - Scientists Doubt Company's Cancer Claim
Scientists are criticizing an Israeli pharmaceutical company's highly- publicized claims that it will have a cure for all forms of cancer within a year.
The researchers used words like "spurious", "highly irresponsible", "unsubstantiated", and even "cruel".
Last week, Accelerated Evolution Biotechnologies Ltd. (AEBI) announced it would soon offer a complete cure for cancer with "no or minimal side-effects at a much lower cost than most other treatments on the market". CEO Dr. Ilan Morad and chairman Dan Aridor told Israeli newspapers that the results of pre-clinical trials have been very good, but Morad claimed the company had not published its research in medical journals because it "can't afford" to do so.
And that was the first red flag, because reputable scientific journals, that are peer reviewed and highly respected, do not charge to publish serious scientific research. But the review process can be rigorous.
Cancer researcher and child cancer survivor Victoria Forster wrote in Forbes that AEBI wasn't very forthcoming with information about its alleged cure: "Delving into what the company does supply, there are two graphs and some pictures taken down a microscope, much less than I provided from a six-week undergraduate research project a decade ago," she wrote. It's also "highly unlikely" that there's one cure that will work for more than 200 known types of cancer.
AEBI says its multi-target toxin works essentially like a cancer antibiotic, and that tests conducted on mice - not humans - were "consistent and repeatable". An official with the American Cancer Society said this approach isn't that unique and that other similar approaches have failed.